Company / SG&A per Share
Oruka Therapeutics, Inc. SG&A per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.78
FY2024
5-year range
$0.38 / $2.50
FY2020-FY2024
Trend
+78.4%
vs FY2023
Sector context
#139 of 210
Health Care
What the data says
At $0.78, Oruka Therapeutics, Inc.'s sg&a per share ranks #72 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 10 years, ranging from $0.38 in FY2022 to $5.01 in FY2019.
Based on SEC 10-K filings.
0.78 in FY2024 with a 5-year CAGR of -31.1%.
Increased from $0.38 to $0.78 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +15.9%
- 5-Year CAGR
- -31.1%
- 10-Year CAGR
- -
Sector benchmark
#72 of 210 in Health CareTop 34% of 210This company $0.78 Sector average $29.50
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share increased 78.4% year-over-year.
- Ranks #139 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
- Lowest sg&a per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.78 | +78.4% |
| FY2023 | $0.44 | +14.2% |
| FY2022 | $0.38 | -23.6% |
| FY2021 | $0.50 | -80.0% |
| FY2020 | $2.50 | -50.2% |
| FY2019 | $5.01 | +1173.6% |
| FY2018 | $0.39 | -16.2% |
| FY2017 | $0.47 | -3.2% |
| FY2016 | $0.49 | -64.0% |
| FY2015 | $1.35 | +426.4% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026